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Introduction
As reported in the cardiology literature, erythromycin is a macrolide antibiotic that prolongs the QT-interval and causes Torsade de Pointes (TdP) [1, 2] . Previous research demonstrated an association between erythromycin, an increased risk of sudden cardiac death and ventricular arrhythmias [3] . This drug prolongs the repolarization phase of an action potential [4] by blocking the component I Kr (rapid delayed rectifying potassium current) of the current through voltage-gated potassium channels [5] [6] [7] [8] . The component I Ks (slow delayed rectifying potassium current) and the inward rectifying potassium current I K1 are unaffected by erythromycin [6] .
The therapeutic blood plasma concentration of erythromycin is 3-8 µM [9] , although the effective concentration may be as high as 30 μ М [2] . In experiments in vitro, erythromycin had a significant effect on the field potential duration (FPD) in human embryonic stem cell-derived cardiomyocytes at concentrations of 1.5-16 µM, but it did not induce proarrhythmic effects [10] .
At physiological temperature, erythromycin blocked hERG channels, with an IC50 (the half maximal inhibitory concentration) at a concentration of 40 μ M [11] . The same effect was achieved by concentrations of erythromycin up to 100 μ M under physiological temperature conditions but not under room temperature (24° С ) conditions [12] . Only a few studies have focused on the mechanism of action of erythromycin in multicellular cardiac experimental models [2, [13] [14] [15] , and the role of this drug in the occurrence of arrhythmias remains unclear. Furthermore, information is lacking on the influence of varying erythromycin concentrations on excitation wave propagation.
In this study, we investigated the role of erythromycin in re-entry formation in a monolayer of human iPSC-derived cardiomyocytes from a healthy donor and in a neonatal rat ventricular myocyte (NRVM) monolayer. The conduction velocity (CV) and maximum capture rate (MCR, the maximum rate at which each stimulus was followed by a response) were evaluated using the optical mapping method at erythromycin concentrations of 15, 30, and 45 μ M. The dose-dependence arrhythmogenicity of erythromycin on a standard linear obstacle was determined. The experiments also demonstrated the mechanism of re-entry formation and the probability of its appearance, which depended on the stimulation frequency and the concentration of erythromycin.
Materials and Methods

Preparation of samples
Pre-fired cover glasses (13 mm in diameter and 22 mm in diameter) were placed in the sterile 24-well culture plates or in Petri dishes. Further, the glasses were burned with ultraviolet for 30 minutes. To improve the adhesion of NRVMs, human fibronectin (Imtek) was used. After application of fibronectin to each cover glass at a concentration of 20 μ g/ml, the Petri dishes were transferred to an incubator (37 °C, 5% CO 2 ) for 12 hours. iPSCs were cultured in the Essential 8™ Medium on a Geltrex LDEV-Free hESC-Qualified Reduced Growth Factor Basement Membrane Matrix (ThermoFisher Scientific) after transferring from the feeder layer. For experiments, iPSCs were seated in the wells of 24-well sterile plates covered with Geltrex. The differentiation protocol started when the 80% of confluence monolayer was formed on day 3-4 after plating. 
Fibroblast derivation and reprogramming to the pluripotent state
Dermal fibroblasts were isolated from a skin biopsy of healthy donor. Fibroblasts were cultivated in the medium contained DMEM:F12 1:1, 15% fetal bovine serum, 1×GlutaMAX TM Supplement, 1×Penicillin-Streptomycin. All reagents were from ThermoFisher Scientific if another supplier is not stated.
Characterization of iPSC lines
Analysis of expression of alkaline phosphatase was performed as described previously [14] . Spontaneous differentiation of the cell lines was performed through embryoid bodies formation [16] . 14-day embryoid bodies were treated with 0.25% trypsin. Cell suspension was plated on 4-well plates and cultivated for 7 days.
Immunofluorescent analysis of iPSCs and their differentiated derivatives was carried out as described below.
Immunofluorescent staining
Cells were fixed for 10 min in 4% paraformaldehyde, permeabilized for 10 min in 0.4% Triton-X100 or 96% ethanol (for TRA-1-60 and TRA-1-81). Immunostaining with antibodies to SSEA-4 was done without 
Preparation of neonatal rat cardiomyocytes
Cardiac cells were isolated according to the Worthington protocol (http://www.worthingtonbiochem.com/NCIS/default.html). In this work the hearts of rats Rattus norvegicus, Sprague Dawley breed aged 1-4 days were used. Seating of the cells occurred for optical mapping at a concentration of 300 thousand/cm 2 drop on the prepared glass. After plating the cells, the samples were placed in an incubator (37 °C, 5% CO 2 ) for 1-2 hours. Then DMEM supplemented with 10% FBS, 2 mM of L-glutamine, and 100 U/ml of penicillin/streptomycin was added to each sample and the samples were returned to the incubator for 24 hours. The next day there was a change of medium on DMEM described above with 5% FBS.
After 3-4 days of cultivation, the cells were observed in a light microscope for the formation of a confluent monolayer and the formation of contractile syncytium, which served as an indicator for the possibility of optical mapping of this sample. Each sample was checked for spontaneous activity. The amplitude of the pulses was not higher than 8V. The video was shot at a speed of 68-130 FPS (frames per second) and a spatial resolution of ~ 0.03 mm / pixel.
Optical mapping of neonatal rat cardiomyocytes
Data processing
All videos from optical mapping were processed in the ImageJ program. The activation maps were built using the Wolfram Mathematica program. The image processing from the confocal microscope was performed in the Zen program corresponding to the microscope software.
Optical mapping of human iPSC-derived cardiomyocytes
Optical mapping of human iPSC-derived cardiomyocytes occurred 50 days after the start of differentiation protocol. The sample incubated in a sterile medium at 37 ° C with a fluor-4 dye in concentration 4 μ g/ml for 30 min. Then the dye solution was exchanged with a sterile Tyrode's solution. All experiments were carried out at a temperature of 37 °C. 
Protocol of optical mapping
Statistics
All experimental numerical data are presented as the mean ± SD unless otherwise specified. The statistical significance was determined using a one-way ANOVA followed by Fisher's least significant difference for comparisons among groups. Values of p < 0.05 were considered statistically significant.
Results
Generation of iPSCs
To generate iPSCs, dermal fibroblasts of a healthy donor were nucleofected with episomal vectors expressed reprogramming factors. Colonies similar to those of human pluripotent cells formed beginning from day 15 after nucleofection. These colonies were cultivated to generate stable cell lines. Seventeen cell lines were derived, and four of these cell lines (m34Sk3, m34Sk4, m34Sk10, and m34Sk13) were selected for further cultivation and characterization.
The cell lines obtained expressed a number of pluripotency markers, such as alkaline phosphatase (Fig.   1A ), transcription factors (OCT4 and NANOG), and surface antigens (SSEA-4, TRA-1-60, and TRA-1-81) (Fig.   1В ). The cell lines underwent spontaneous differentiation through embryoid body formation The differentiated derivatives obtained during spontaneous differentiation expressed markers of three germ layers: ectoderm (beta-III-tubulin), endoderm (cytokeratin 18), and mesoderm (CD90, smooth muscle α -actin) (Fig. 1С ). Expression of pluripotency markers and capacity to be differentiated into three germ layer derivatives confirmed the pluripotent state of the cell lines obtained.
Directed differentiation of iPSCs into cardiomyocytes
The method based on WNT/β-catenin activation by inhibition of the GSK3 protein kinase with CHIR99021, followed by WNT repression (with IWP2) [17] was applied to induce iPSC differentiation into cardiomyocytes.
One of the iPSC lines, m34Sk3, was differentiated into cardiomyocytes, with the first spontaneous contractions observed on day 9. The analysis of single differentiated cells revealed the expression of sarcomeric proteins (cardiac troponin T, ventricular form of β -myosin regulatory light chain, and β -myosin heavy chain) and cardiomyocyte transcription factor NKX2.5 in a proportion of the cells (Fig. 2) .
Optical mapping of human iPSC-derived cardiomyocytes
In the first set of experiments, monolayers of human iPSC-derived cardiomyocytes were used to evaluate excitation wave propagation under erythromycin concentrations of 15, 30, and 45 µM. The results revealed that the CV was changed insignificantly (the maximal decrease 12±9% under 30 µM) under these concentrations ( Fig. 3A) and that the maximum capture rate decreased up to 28±12% (Fig. 3B, p < 0.05) . The latter effect was irreversible after washout of erythromycin.
Second, we evaluated the formation of re-entry on a standard linear obstacle situated perpendicular to the direction of excitation wave propagation. The frequency of external impulses was increased from 1 Hz to 3.33 Hz in increments of ≤ 0.5 Hz. Figure 4 shows the activation maps of the human iPSC-derived cardiomyocyte monolayer with the obstacle at a stimulation frequency of 2.5 Hz in the control (4A) and when exposed to an erythromycin concentration of 15 µM (4B). 
Optical mapping of NRVMs
In the second set of experiments, excitation wave propagation in NRVM monolayers under erythromycin concentrations of 15, 30, and 45 µM was evaluated. The MCR was stable (a decrease of less than 9±8%) under these concentrations (Fig. 6A ). Re-entry did not occur at all the concentrations of erythromycin (15, 30, and 45 µM) . Figure 6C demonstrates the successful excitation wave propagation in NRVM monolayer with the standard linear obstacle under 15 µM erythromycin at stimulation frequency of 3.33 Hz.
Discussion
In the last decade [16, 17] in pharmacology, cell assays have been widely used for drug testing. Today, cellular assays can exploit cell reprogramming [10, 20] . Using this technology, adult cells of a living organism can be reprogrammed into a pluripotent state. Following further differentiation of these cells, human cells with specific properties can be obtained in vitro [19] [20] [21] .
In standard cardiotoxicity assays, a chemical substance is used to inhibit hERG channels to identify possible side effects namely the occurrence of life-threatening arrhythmias, e.g. TdP, associated with the substance [24, 25] . Few studies show the effect of arrhythmogenic drugs on arrhythmic beating, changes in beat rate [2] and FPD [14] using monolayers of human iPSC-derived cardiomyocytes (iCell®). Shaheen et al. ArcLight for evaluation of conduction slowing and APD prolongation under chemical compounds [15] . In addition, the developing systems [26] of patient-specific human iPSC-derived cardiomyocytes consider a single cell level. A shortcoming of existing methods of drug testing for cardiotoxicity based on iPSCs is a small consideration of the drug effect on intercellular contacts and conduction of excitation in multicellular, syncytium-forming systems.
To enhance the reliability of cardiotoxicity testing systems, we propose a method for determining the arrhythmogenicity of the substance based on evaluating re-entry formation on a standard linear obstacle in cardiomyocyte monolayer by optical mapping. We validated the proposed method in two model systems: a monolayer of human iPSC-derived cardiomyocytes from healthy donor and a monolayer of NRVM. As a test substance, erythromycin, a representative macrolide antibiotic that prolongs the QT interval and potentially induces TdP, was used.
In the experiments on the dose dependence of the conduction velocity (CV) and maximum capture rate (MCR) of the excitation wave in the monolayers of human iPSC-derived cardiomyocytes the CV varied insignificantly (up to 12 ± 9%) at erythromycin concentrations of μ M as compared with that of the control, whereas the MCR fell substantially (to 28 ± 12%) at these concentrations. As the MCR of stimulation corresponds to the total duration of the action potential and the period of refractoriness, the decrease in this parameter points to prolongation of the sum of the above characteristics and indirectly confirms the action of erythromycin on the I Kr current. This potassium current is present in human cells but absent in rat cells. In the experiments on MCR in the monolayer of rat cardiomyocytes, no similar effects were obtained, and the MCR changed insignificantly when exposed to erythromycin at concentrations of μ M (Fig. 6A) . These findings confirm the results of a previous study on the effect of erythromycin on the I Kr current [5] [6] [7] [8] and the lack of any effect on the I Ks current [6] . 
Conclusions
The proposed test method, which is based on a comparison of MCR in human iPSC-derived cardiomyocyte and 
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